729
Participants
Start Date
July 15, 2021
Primary Completion Date
February 6, 2024
Study Completion Date
November 12, 2026
Deucravacitinib
Specified dose on specified days
Placebo
Specified dose on specified days
Apremilast
Specified dose on specified days
Local Institution - 0090, Taichung
Local Institution - 0089, Taichung
Local Institution - 0197, Budapest
Local Institution - 0078, Brussels
Local Institution - 0200, Buenos Aires
Local Institution - 0038, San Isidro
Local Institution - 0048, La Plata
Local Institution - 0003, Botany
Local Institution - 0027, Kistarcsa
Local Institution - 0018, Paramatta
Local Institution - 0002, Camberwell
Local Institution - 0017, Geelong
Local Institution - 0171, San Miguel de Tucumán
Local Institution - 0061, Liège
Local Institution - 0066, Debrecen
Local Institution - 0004, Maroochydore
Local Institution - 0099, Woodville
Local Institution - 0028, Gyula
Local Institution - 0024, Hódmezővásárhely
Local Institution - 0025, Veszprém
Local Institution - 0058, Ghent
Local Institution - 0091, Taipei
Local Institution - 0108, New York
Local Institution - 0087, Taipei
Local Institution - 0011, Prague
Local Institution - 0198, Mexico City
Local Institution - 0186, Rochester
Local Institution - 0016, Duncansville
Local Institution - 0046, Hamburg
Local Institution - 0169, Cumberland
Local Institution - 0012, Madrid
Local Institution - 0196, Charlotte
Local Institution - 0182, Summerville
Local Institution - 0053, Chihuahua City
Local Institution - 0201, Minden
Local Institution - 0129, Wenzhou
Local Institution - 0149, Mountain Brook
Local Institution - 0052, León
Local Institution - 0045, Santander
Local Institution - 0075, Magdeburg
Local Institution - 0109, Hattiesburg
Local Institution - 0176, Ratingen
Local Institution - 0203, Hopkinsville
Local Institution - 0180, Cleveland
Local Institution - 0051, Guadalajara
Local Institution - 0057, Zapopan
Local Institution - 0013, Valencia
Local Institution - 0034, Okemos
Local Institution - 0019, Medellín
Azienda Ospedaliera Universitaria Careggi-Reumatologia, Florence
Local Institution - 0101, Cologne
Local Institution - 0190, Franklin
Local Institution - 0175, Milwaukee
Local Institution - 0133, Eagan
Local Institution - 0192, Skokie
Local Institution - 0195, Baton Rouge
Local Institution - 0074, Tübingen
Local Institution - 0189, Oklahoma City
Local Institution - 0184, Plano
Local Institution - 0070, Mesquite
Local Institution - 0167, Lubbock
AOR San Carlo di Potenza-UOC Reumatologia, Potenza
Local Institution - 0188, Whittier
Local Institution - 0199, Erlangen
Local Institution - 0212, Sacramento
Local Institution - 0056, Mérida
Local Institution - 0147, Portland
Local Institution - 0187, Seattle
Local Institution - 0152, Beijing
Local Institution - 0146, Beijing
Local Institution, Moscow
Local Institution - 0015, Bogotá
Local Institution - 0207, Shanghai
Local Institution - 0138, Nanjing
Local Institution - 0125, Changzhou
Local Institution - 0163, Wuxi
Local Institution - 0139, Nantong
Local Institution - 0126, Bengbu
Local Institution - 0022, Chía
Local Institution - 0131, Nanchang
Local Institution - 0156, Nanchang
Local Institution - 0148, Jiujiang
Local Institution - 0140, Pingxiang
Local Institution - 0088, Taichung
Local Institution - 0170, Changsha
Local Institution - 0161, Changsha
Local Institution - 0127, Zhengzhou
Local Institution - 0153, Guangzhou
Local Institution - 0135, Guangzhou
Local Institution - 0206, Shenzhen
Local Institution - 0164, Chengdu
Local Institution, Novosibirsk
Local Institution - 0134, Kunming
Local Institution - 0154, Xi'an
Local Institution - 0020, Santiago de Cali
Local Institution - 0117, Ürümqi
Local Institution - 0178, Meguro-ku
Local Institution - 0106, Nagoya
Local Institution - 0039, CABA
Local Institution - 0111, Vancouver
Local Institution - 0006, Hamilton
Local Institution - 0030, Markham
Local Institution - 0036, Toronto
Local Institution - 0001, Québec
Local Institution - 0158, Baotou
Local Institution - 0157, Hohhot
Local Institution - 0072, Barranquilla
Local Institution - 0010, Brno
Local Institution - 0009, Ostrava
Local Institution - 0035, Ostrava
Local Institution - 0023, Uherské Hradiště
Local Institution - 0097, Roma
Local Institution - 0202, Nagoya
Local Institution - 0151, Sapporo
Local Institution - 0179, Tsu
Local Institution - 0123, Kawachi-Nagano
Local Institution - 0205, Bunkyō
Local Institution - 0121, Chuo-ku
Local Institution - 0067, Itabashi-ku
Local Institution - 0122, Minato-ku
Local Institution - 0174, Mitaka
Local Institution - 0065, Shinjuku-ku
Local Institution - 0155, Fukuoka
Local Institution - 0166, Osaka
Local Institution - 0204, Osaka
Local Institution - 0082, Bydgoszcz
Local Institution - 0177, Warsaw
Local Institution - 0079, Gdansk
Local Institution - 0080, Elblag
Local Institution - 0081, Torun
Local Institution - 0112, Wroclaw
Local Institution - 0014, Barcelona
Local Institution - 0185, London
Local Institution - 0060, Bradford
Local Institution - 0064, Hull
Local Institution - 0077, Liverpool
Local Institution - 0062, London
Local Institution - 0105, Manchester
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY